GL1X · GenesisL1 explorer

MolNFT v1 · #125007 · protein

The extra-helical binding site of GPR40 and the structural basis for allosteric agonism and incretin stimulation

5KW2 · Free fatty acid receptor 1,LYSOZYME,FREE fatty acid…: “The extra-helical binding site of GPR40 and the structural basis for allosteric agonism and incretin…”. X-ray diffraction, 1 ligand (6XQ), 4 pockets (best druggability 0.56).…

PDB
5KW2
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Free fatty acid receptor 1,LYSOZYME,FREE fatty acid receptor 1
EC
3.2.1.17
UniProt
O14842, D9IEF7
Ligands
6XQ
Pockets
4 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 75% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFree fatty acid receptor 1,LYSOZYME,FREE fatty acid receptor 1 (EC 3.2.1.17)protein41175% helix, 4% strandO14842, D9IEF7

Ligands and binding sites

  • 6XQ · (3~{S})-3-cyclopropyl-3-[2-[1-[2-[2,2-dimethylpropyl-(6-methylpyridin-2-yl)carbamoyl]-5-methoxy-phenyl]piperidin-4-yl]-1-benzofuran-6-yl]propanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12500.560.7731empty
21710.480.76276XQ
3720.390.7913empty
4500.280.7511empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 5KW2 · The extra-helical binding site of GPR40 and the structural basis for allosteric agonism… · the same entry in another collection · chain A against A, TM-score 1.00
  • O14842 · AlphaFold monomer V2.0 prediction for free fatty acid receptor 1 (O14842) · a predicted model of the same protein · chain A against A, TM-score 0.58

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.